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WhenDr. Igarashi, Chairman of the Organizing Committee, invited meto participate
in this symposium, I thought I should decline his gracious offer because I am not a dengue
specialist. I was afraid I would not be able to contribute to this symposium. But after
reading some of his review articles on dengue virus infection, I immediately understood
why he so insisted that I attend this meeting. I now realize how important and necessary
it is for us, NIH researchers, to play a greater role in the research of dengue haemorrhagic
fever (DHF)/dengue shock syndrome (DSS).
Frankly speaking, after hearing so many interesting and stimulating presentations
and enthusiastic discussions concerning prevention and control of dengue virus infection, I
amthankful to Dr. Igarashi for inviting me to attend this meeting.
On the first day of this symposium, recent epidemiological features of dengue were
reported from a global point of view by Dr. Scott Halstead and Dr. Nobuhiko Okabe, and
country reports were made by many speakers who were invited from both tropical and
subtropical countries. All of the data attests that DHF is one of the major public health
problems in the South-East Asian and Western Pacific regions, and Central and South
America.
First of all, I was very interested to discover through the symposium that there have
been many observations concerning dengue which are presently hard to explain and so
remain yet unanswered. For example,
1 ) Variable case fatality rates of DHF/DSS have been reported among different coun-
tries as well as in different years in the same country.
2 ) No noticeable differences have been found in both genetic analysis and biological
marker tests amongisolates from severe and mild dengue cases, suggesting that the same
virus could develop a variety of clinical manifestations from unknown host factors of
different circumstances, or that genetic analysis may be inadequate to prove the presence
or absence of more virulent strains, even if they exist.
3 ) Viral virulence, or manifestation of clinical symptoms, may possibly be associated
with genetic factors as suggested by epidemiological observations of the relative absence
of severe cases of the disease among Blacks during the Cuban outbreaks of dengue in 1981.
4 ) It has not yet been clarified whether the virus itself, or a certain specific condition of
the host, such as immune-enhancement mechanism, plays the dominant role in the path-
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and other developed countries are far ahead of Japan in these respects. In fact, there are
manyAmerican scientists who specialize in international medical cooperation for develop-
ing countries. In contrast, there are very few such institutes in Japan. However, our
Ministry of Health and Welfare has just founded the National Medical Center for Interna-
tional Cooperation in Tokyo. We greatly hope for its success in the future.
NowI would like to refer to a more fundamental problem we have in persuing
international copperation. That is the absence of effective communication between two
nations working together. In most cases, this problem, arises from language barriers.
But it is also a result of a lack of knowledge about other countries. For most Japanese,
English is the only other language they can use to communicate with the people from other
countries. This limitation compounds problems as, in most cases, English is not the native
language for both collaborating countries. In addition, traditionally, many Japanese tend
to be shy and bad at socializing. These factors often lead to misunderstanding in interna-
tional settings. These cultural misunderstandings can raise serious problems and cause
conflicts among collaborating nations. Therefore, it is of the utmost importance to make
efforts to study and understand the cultural backgrounds and the differences in customs
and manners of out international partners in order to foster a more favorable environment
for collaboration. Presently, this type of education is the individual's responsibility.
However, I strongly believe that the aforementioned efforts should be made collectively
through overseas research training.
Regarding dengue, in particular, work at the Institute of Tropical Medicine, Nagasa-
ki University and the International Center for Medical Research in Kobe, and a few other
institutions form the core of its research efforts. All these institutions are, however, under
the tutelage of the Ministry of Education, Science and Culture and at this moment there are
few dengue virus specialists in laboratories under the supervision of the Ministry of Health
and Welfare. I must admit we are entirely responsible for this matter, and honestly, I'm
grateful to Dr. Igarashi for giving me the opportunity to reassess our current stance
towards the international collaboration on dengue research. In the future we must
approach this situation more seriously, and make efforts to change it.
Finally, after hearing so manywell articulated and cogent presentations and discus-
sions, I am now convinced that we must make stronger appeals to the government and
NGO to unite with us towards an international collaboration on dengue research.
Now,I would like to conclude my speech adding some words of appreciation as one
of the organizing committee members.
I am extremely pleased that all of us today were able to obtain the most up-to-date
information on epidemiology, and prevention and control of dengue virus infection. Also,
wewere supplied with the productive opinions of experts from such diverse fields as
virology, immunology, entomology, clinical medicine, and public health administration.
Needless to say, our guest speakers' excellent presentations and our participants' enthusi-
astic discussions over the past two days made these accomplishments possible. Sympo-
siums of this nature are indispensable for the promotion and achievement of our goals.
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ogenesis of severe dengue.
To answer these questions, WHO's global strategy for dengue prevention and
control emphasizes the importance of improved surveillance and well designed
epidemiological investigations using more advanced techniques. We believe that the
organization and implementation of the international collaborative research project on
dengue epidemiology will provide valuable and indispensable information for planning
vector control measures and vaccine development strategies, as well as for understanding
the pathogenesis of DHF/DSS.
Second, thus far we have had many heated discussions on strategies for efficient
dengue vector control and its research. Consequently, as there is an urgent need for one,
professional vector control organization through international cooperation has been
proposed. In addition, although it was noted in recent discussions that Aedes aegypti plays
the predominant role in transmitting DHF, the role of Ae. albopicus still remains ambigu-
ous and needs to be more carefully studied.
Third, international collaboration on vaccine development research has been fer-
vently promoted by WHO. In addition, on-going vaccine studies and future plan have
been described by Dr. Natth Bhamarapravati and Dr. Kotaro Yasui, and then summarized
by Dr. Takashi Kitamura. I would like to particularly emphasize that the establishment
of a good animal model in which the efficacy and safety of dengue vaccines can be tested
is essential for the development of high quality, safe vaccines to meet WHO's minimum
requirements.
My greatest concern is how international research cooperation has been conducted
in countries where dengue is endemic. In this respect, I would like to talk about some
problems or issues we face in international research copperation. To begin, a problem lies
in the fact that the number of experts on infectious diseases, with the exception of AIDS,
is generally decreasing among industrialized nations. Japan is a prominent example. In
other words, there are not enough medical scientists or researchers who are available for
research cooperation. In addition, most of the few, qualified experts are enormously busy
with their ownresearch and institutional duties. Consequently, they are unable or rather
reluctant to devote their time to important work such as transfering technology to
developing countries. This practice is a prerequisite for the successful implementation of
international research collaboration. Since DHF is prevalent primarily in tropical and
subtropical countries, the importance of locating bases for dengue research in these actual
risk areas is clear. Therefore, it is necessary for experts to visit and stay for long periods
of time sufficient to share technology and collaborate on research. Regrettably, most
Japanese research institutes still do not properly acknowledge such activities as significant
accomplishments in one's research career. Ironically, these activities inadvertently dis-
courage promotions as they monopolize time that would be otherwise spent writing
research papers. Moreover, it is generally difficult for one to even return to the same
work place after working abroad for an extended period of time. Perhaps, we must
reassess the criteria for the evaluation of ones scientific carreer. It seems that the USA
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As Dr. Norman Gratz of WHO commented on the first day, "This conference is only
the beginning of dengue control study." I strongly believe the final objective of dengue
control will only be met efficiently and successfully through international research coopera-
tion.
Again, I would like to close my presentation by thanking Dr. Igarashi and his
colleagues here in Nagasaki.
